David Sachs

CFO

Chief Accounting Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

IBRX

Current role

CFO, Chief Accounting Officer

2021-03-05–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	ImmunityBio, Inc. (IBRX)	CFO	$591,711	$66,974	$836,347	$2,506,022	$229,336	$14,153	$4,244,543
2024	ImmunityBio, Inc. (IBRX)	Chief Financial Officer	$574,515	—	$639,023	$1,923,937	$230,143	$13,989	$3,381,607
2023	ImmunityBio, Inc. (IBRX)	Chief Financial Officer	$537,525	$273,980	$233,457	—	—	$13,120	$1,058,082
2022	ImmunityBio, Inc. (IBRX)	Chief Financial Officer	$521,039	—	—	$1,128,235	—	$12,288	$1,661,562
2021	ImmunityBio, Inc. (IBRX)	Chief Financial Officer	$423,451	$35,625	$4,303,544	—	$166,250	$7,807	$4,936,677
2020	ImmunityBio, Inc. (IBRX)	Chief Financial Officer	$442,999	$193,500	—	—	—	$7,097	$643,596

No earnings-call appearances or filed executive changes recorded yet.